Deep venous thrombosis and pulmonary embolism in a patient with hemoperitoneum

Authors

  • Laura Limia-Pérez Unidad de Medicina Interna y Unidad de Lípidos y Arteriosclerosis. IMIBIC/Hospital Universitario Reina Sofía/Universidad de Córdoba. Córdoba. España
  • Juan Criado-García Unidad de Medicina Interna y Unidad de Lípidos y Arteriosclerosis. IMIBIC/Hospital Universitario Reina Sofía/Universidad de Córdoba. Córdoba. España
  • María Fuentes-Spínola Servicio de Medicina Interna. Hospital San Juan de la Cruz. Úbeda (Jaén). España
  • Ana Cristina Delgado-Zamorano Unidad de Medicina Interna y Unidad de Lípidos y Arteriosclerosis. IMIBIC/Hospital Universitario Reina Sofía/Universidad de Córdoba. Córdoba. España
  • María Gracia Cruz-Caparrós Servicio de Medicina Interna. Hospital de Poniente. El Ejido (Almería). España

DOI:

https://doi.org/10.32818/reccmi.a3n2a15

Keywords:

venous thromboembolism, deep venous thrombosis, pulmonary embolism, vena cava filter.

Abstract

The mainstay of the treatment of venous thromboembolism is anticoagulation. Vena cava filters should be considered when there is a contraindication for anticoagulant treatment, a complication of anticoagulation resulting in cessation of therapy or pulmonary embolism recurrence during therapeutic anticoagulation. We present the management of a case of thromboembolic disease in a cancer patient who developed a hemoperitoneum.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007; 98: 756-764.

Greenfield LJ. Evolution of venous interruption for pulmonary thromboembolism. Arch Surg. 1992; 127: 622-626.

Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du risque d’embolie pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998; 338: 409-415.

Mismetti P, Laporte S, Pellerin O, Ennezat PV, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015; 313: 1627-1635.

Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J Am Coll Cardiol. 2017; 70: 1587-1597.

Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl): 381S-453S.

Kaufman JA, Kinney TB, Streiff MB, Sing RF, Proctor MC, Becker D, et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol. 2006; 17: 449-459.

Howard LS, Hughes RJ. NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. Thorax. 2013; 68: 391-393.

Published

2018-08-31

How to Cite

1.
Limia-Pérez L, Criado-García J, Fuentes-Spínola M, Delgado-Zamorano AC, Cruz-Caparrós MG. Deep venous thrombosis and pulmonary embolism in a patient with hemoperitoneum. Rev Esp Casos Clin Med Intern [Internet]. 2018 Aug. 31 [cited 2024 Dec. 22];3(2):90-2. Available from: https://www.reccmi.com/RECCMI/article/view/293

Similar Articles

You may also start an advanced similarity search for this article.